Distribution of osteopontin and calprotectin as matrix protein in calcium-containing stone.
We recently reported that osteopontin (OPN) and calprotectin (CPT) are present in the matrix of urinary calcium stones, and that OPN mRNA is expressed in the renal distal tubular cells. In the present study, we examined the immunohistochemical distributions of OPN and CPT in urinary stones. The stones used in this study were passed spontaneously from the upper urinary tract. One half of each of the stones was analyzed with an infrared spectrophotometer, and were shown to be comprised of calcium oxalate, calcium phosphate, uric acid and cystine. The other half of each stone was immersed in tetrasodium ethylenediamine-tetraacetate (EDTA) solution. The half-stones were embedded in paraffin and cut into 5-microm sections. The avidin-biotin-peroxidase complex technique was employed. A monoclonal antibody to human milk-derived OPN and a monoclonal antibody to human granulocyte-derived CPT were used as primary antibodies. The immunochemical study using the OPN and CPT antibodies showed positive staining of the matrix of the urinary calcium stones. The stones showed staining in two distinct zones: a core area was stained with randomly aggregated OPN and CPT, and peripheral layers were stained in concentric circles. On the basis of our observations, it is reasonable to presume that OPN and CPT play roles as the matrix in the structure of urinary calcium stones.
Tawada
T
T
Department of Urology, Nagoya City University School of Medicine, Nagoya, Japan.
Fujita
K
K
Sakakura
T
T
Shibutani
T
T
Nagata
T
T
Iguchi
M
M
Kohri
K
K
D000818:Animals; D000911:Antibodies, Monoclonal; D002118:Calcium / Q000032:analysis*; D002129:Calcium Oxalate / Q000032:analysis; D002130:Calcium Phosphates / Q000032:analysis; D003553:Cystine / Q000032:analysis; D004797:Enzyme-Linked Immunosorbent Assay; D006801:Humans; D007150:Immunohistochemistry; D039841:Leukocyte L1 Antigen Complex; D008562:Membrane Glycoproteins / Q000032:analysis / Q000276:immunology / Q000378:metabolism*; D051379:Mice; D008807:Mice, Inbred BALB C; D019006:Neural Cell Adhesion Molecules / Q000032:analysis / Q000276:immunology / Q000378:metabolism*; D053495:Osteopontin; D012795:Sialoglycoproteins / Q000032:analysis / Q000276:immunology / Q000378:metabolism*; D014527:Uric Acid / Q000032:analysis; D014545:Urinary Calculi / Q000737:chemistry / Q000378:metabolism*
D000911:Antibodies, Monoclonal; D002130:Calcium Phosphates; D039841:Leukocyte L1 Antigen Complex; D008562:Membrane Glycoproteins; D019006:Neural Cell Adhesion Molecules; C506895:SPP1 protein, human; D012795:Sialoglycoproteins; C506896:Spp1 protein, mouse; C485828:alpha-tricalcium phosphate; C485830:tetracalcium phosphate; D053495:Osteopontin; D002129:Calcium Oxalate; D014527:Uric Acid; D003553:Cystine; C485838:calcium phosphate, monobasic, anhydrous; C020243:calcium phosphate; C485829:calcium phosphate, dibasic, anhydrous; D002118:Calcium